SCHEDULE: ReNew Energy Global Receives $8.15/Share Buyout Offer
Acquisition Proposal Update
A consortium including founder Sumant Sinha has submitted a best and final non-binding proposal to acquire all outstanding shares of ReNew Energy Global plc for $8.15 per share in cash.
Summary
- A consortium, including founder Sumant Sinha, Canada Pension Plan Investment Board (CPPIB), Abu Dhabi Future Energy Company PJSC-Masdar (Masdar), and Platinum Hawk C 2019 RSC Limited, submitted a revised non-binding proposal to acquire all shares of ReNew Energy Global plc not currently owned by the Consortium.
- The offer price is $8.15 per share, payable in cash, for the entire issued and to be issued share capital.
- This represents a 29% premium to the closing share price of $6.34 on December 10, 2024, and a 41% premium to the 30-day volume-weighted average price of $5.76 as of December 10, 2024.
- The proposal is explicitly stated as the Consortium's 'best and final non-binding offer'.
- The transaction is expected to be implemented through a UK scheme of arrangement.
- The Consortium aims to announce a binding transaction in November 2025.
- Founder Sumant Sinha beneficially owns 54,949,300 shares, representing 18.4% of the class.
- The combined beneficial ownership of the Reporting Person, CPPIB, and Platinum Hawk is approximately 64.80% of the outstanding shares on a fully diluted basis.
Sentiment
Score: 8
Explanation: The filing details a significantly increased, 'best and final' acquisition offer with a substantial premium to recent trading prices, indicating a strong positive for current shareholders seeking liquidity. The progress on due diligence and transaction documentation also suggests a high likelihood of the deal proceeding.
Positives
- The increased offer price of $8.15 per share provides immediate liquidity and value certainty for shareholders.
- The offer represents a significant premium: 29% over the closing price of $6.34 on December 10, 2024, and 41% over the 30-day volume-weighted average price of $5.76 as of December 10, 2024.
- The Consortium has completed due diligence, with only confirmatory legal and tax items remaining, indicating a clear path forward.
- Significant progress has been made on the Transaction Agreement, suggesting a high likelihood of a binding deal being reached.
Negatives
- The proposal is explicitly stated as the 'best and final non-binding offer,' indicating that no further price increases are expected.
- The proposal remains non-binding until definitive agreements are executed and delivered, introducing a degree of uncertainty.
- The transaction is subject to numerous conditions, including regulatory approvals, shareholder approval, and warrant redemption, which could delay or prevent completion.
Risks
- The proposal is non-binding and may not lead to a definitive agreement.
- Failure to obtain necessary regulatory approvals in identified jurisdictions.
- Lack of approval from the Company's shareholders or the UK Court sanctioning the scheme of arrangement.
- Inability to redeem all Company warrants or amend the warrant agreement.
- Failure to obtain certain approvals related to the Company's existing financings and other agreements.
- Warranties from the Company not being materially true and accurate.
- The Company being in material breach of its obligations under the Transaction Agreement.
- Potential for delays in the indicative timeline for transaction implementation.
Future Outlook
The Consortium aims to work towards the announcement of a binding transaction in November 2025, with an indicative timeline for completion of the UK scheme of arrangement within 7-8 months post-signing, and a long stop date of 12 months.
Management Comments
- The Consortium believes that its revised proposal, which would provide the Company's shareholders with immediate liquidity and value certainty not available in public markets, would be in the best interest of the Company and its shareholders.
- The Consortium trusts that it evidences its willingness to take the Transaction forward to the next stage.
- The Consortium would like to work towards announcing a binding Transaction in November 2025.
- We are pleased to confirm that no material items remain outstanding in our due diligence exercise.
Industry Context
This filing reflects a trend of consolidation and private equity interest in the renewable energy sector, where established players or consortiums seek to acquire companies to expand their portfolios or take them private for strategic reasons, often leveraging stable cash flows and growth potential. The offer provides immediate liquidity in a sector that can be capital-intensive and subject to policy changes.
Comparison to Industry Standards
- The proposed premium of 29% to the closing share price and 41% to the 30-day volume-weighted average price is generally considered attractive for a take-private transaction, offering shareholders a significant uplift compared to recent market trading.
- While specific comparable companies or projects are not detailed in the filing, such premiums are often evaluated against similar transactions in the renewable energy or infrastructure sectors, where premiums can vary based on growth prospects, asset quality, and market conditions.
- The use of a UK scheme of arrangement is a standard mechanism for takeovers of UK-incorporated public companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Independent Directors | NA | NA | On or shortly after completion of the Transaction | Termination in line with engagement letters upon transaction completion. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Warrant Agreement Amendment | Company to launch a consent solicitation to amend the warrant agreement to allow redemption of warrants at Black-Scholes Value immediately prior to the scheme becoming effective. May combine with a tender offer. | Upon signing of Transaction Agreement (for consent solicitation launch) | Ensures all warrants are redeemed, simplifying the capital structure for the acquiring consortium. |
| Company Articles Amendment | Company's articles will need to be amended to include a provision allowing one or more Consortium members to acquire any Class A shares issued following warrant exercise post-completion for consideration equal to the offer price. | Prior to or upon completion of the Transaction | Ensures consistency in acquisition price for all shares, including those from warrant exercises, and provides a clear mechanism for the Consortium to consolidate ownership. |
Related Party Transactions
- Sumant Sinha, the founder and CEO, is a key reporting person and a member of the Consortium making the acquisition proposal.
- Cognisa Investment and Wisemore Advisory Private Limited, which hold significant shares, are directly owned and controlled by Mr. Sinha.
- The Consortium members (other than the Founder) and the Founder are in material agreement on the principal terms of the ESOP and compensation plan for the Founder and CEO.
Stakeholder Impact
- Shareholders will receive immediate liquidity and a significant premium ($8.15 per share) for their shares, which is likely to be viewed favorably, especially given the 'best and final' nature of the offer.
- Warrant holders are expected to have their warrants redeemed at Black-Scholes Value, providing a clear exit strategy.
- Employees (management team) are subject to a compensation plan for the Founder and CEO, and a similar plan for the broader management team, indicating retention efforts.
- Independent directors' appointments will be terminated upon completion of the transaction.
Next Steps
- Agreeing on the Transaction Agreement between the Company and the Consortium.
- Consortium members seeking final internal approvals to enter into the Transaction Agreement.
- Company launching a consent solicitation process to amend the warrant agreement.
- Submission of regulatory approval filings.
- Company submission of 13E-3 and scheme document to the SEC for review.
- Publication of the scheme document by the Company.
- Company shareholder meeting to approve the Transaction.
- UK Court sanctioning the scheme of arrangement.
- Satisfaction of all conditions precedent to completion of the Transaction.
Key Dates
| Date | Description |
|---|---|
| 2021-09-02 | Original Schedule 13D filed with the SEC. |
| 2022-11-21 | Amendment to Original Schedule 13D. |
| 2023-11-30 | Amendment to Original Schedule 13D. |
| 2024-12-10 | Closing share price of $6.34, used as a benchmark for the premium calculation. Also, date of previous amendment. |
| 2025-03-31 | Date as of which 244,405,376 Class A ordinary shares were outstanding, as reported in the Issuer's Annual Report on Form 20-F. |
| 2025-07-02 | Amendment to Original Schedule 13D. |
| 2025-07-30 | Date Issuer filed its Annual Report on Form 20-F with the SEC. |
| 2025-09-22 | Consortium's advisers shared a draft amendment to the warrant agreement with Linklaters. |
| 2025-10-10 | Date of event requiring filing of this statement; Consortium submitted the Revised Proposal of $8.15 per share; Date of the Revised Proposal letter; Date for Black-Scholes Value calculation for warrants. |
| 2025-11-XX | Target month for announcing a binding Transaction. |
| D + 4 weeks | Indicative timing for submission of regulatory approval filings post-signing. |
| D + 6 weeks | Indicative timing for Company submission of 13E-3 and scheme document to the SEC for review post-signing. |
| D + 11/12 weeks | Indicative timing for publication of scheme document by the Company post-signing. |
| D + 15/16 weeks | Indicative timing for Company shareholder meeting post-signing. |
| D + 7-8 months | Indicative timing for satisfaction of conditions precedent and UK Court sanction of scheme of arrangement post-signing. |
| D + 12 months | Indicative long stop date for the transaction post-signing. |
Recommendation
strong buyThe filing details a 'best and final' non-binding offer at $8.15 per share, representing a substantial premium of 29% to the closing price and 41% to the 30-day VWAP as of December 10, 2024. The consortium, including the founder, has completed due diligence and made significant progress on documentation, indicating a high probability of the transaction closing. For investors, this offers a clear, attractive exit price with immediate liquidity and value certainty, making it a strong buy for arbitrage or to capture the premium.
Keywords
ReNew Energy Global plc, RNW, Sumant Sinha, Consortium, Acquisition, Buyout, Takeover, Renewable Energy, SEC Filing, Schedule 13D, Offer Price, Shareholder Value, CPPIB, Masdar, Platinum Hawk
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.